🔎 Trials Near Me

Home › Ovarian Cancer › Arizona › Phoenix

Ovarian Cancer clinical trials in Phoenix, AZ

11 studies for Ovarian Cancer are looking for participants at sites in and around Phoenix (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

RecruitingObservational study
  • Mayo Clinic, Phoenix
Ages 18 and older · Women · Updated Sep 29, 2026 · NCT05051722

A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

RecruitingPhase 2
  • Site 0143 - HonorHealth, Phoenix
Ages 18 and older · Women · Updated Sep 29, 2026 · NCT05128825

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

RecruitingObservational study
  • Mayo Clinic Hospital, Phoenix
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT04981119

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

RecruitingPhase 3
  • HonorHealth, Phoenix
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07213804

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

RecruitingPhase 3
  • Cancer Center at Saint Joseph's, Phoenix
  • Mayo Clinic Hospital in Arizona, Phoenix
Ages 18 and older · All sexes · Updated Aug 7, 2026 · NCT06580314

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

RecruitingPhase 1/2
  • USOR HonorHealth, Phoenix
Ages 18 and older · All sexes · Updated Aug 4, 2026 · NCT05579366

Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)

RecruitingPhase 3
  • Mayo Clinic Arizona, Phoenix
Ages 18 and older · Women · Updated Jul 14, 2026 · NCT05804370

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

RecruitingPhase 1/2
  • Mayo Clinic Comprehensive Cancer Center, Phoenix
Ages 18 and older · All sexes · Updated Jun 29, 2026 · NCT05377996

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

RecruitingPhase 1/2
  • Mayo Clinic, Phoenix
Ages 18 and older · All sexes · Updated Mar 27, 2026 · NCT06395519

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

RecruitingPhase 2
  • Mayo Clinic Hospital, Phoenix
Ages 18 and older · Women · Updated Dec 23, 2025 · NCT06690775

About Ovarian Cancer

Ovarian cancer is a cancerous tumor that forms in the tissues of an ovary. The ovaries are a pair of female reproductive glands that make eggs and female hormones.

More about Ovarian Cancer on MedlinePlus

Ovarian Cancer trials in other cities

Other studies in Phoenix

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.